Tirzepatide Prefilled Pen

Tirzepatide Prefilled Pen

The Tirzepatide Prefilled Pen contains Tirzepatide, a synthetic peptide described in research as a dual agonist (GLP-1 and GIP), in a prefilled dosing pen for accurate volume delivery in research setups.

Research context

Tirzepatide is studied in relation to the simultaneous activation of two receptor pathways in energy and glucose metabolism. The prefilled pen supports consistent dosing in comparative research. Intended for research use only.

Specifications

• Compound: Tirzepatide
• Form: prefilled dosing pen
• Available dosages: 20 mg, 30 mg, 50 mg
• Purity: >99% (HPLC verified)

Storage

Store refrigerated according to the provided instructions.

Disclaimer

For laboratory and research use only. Not for human or animal consumption, and not for diagnostic or therapeutic use.

Certificate of Analysis

Independently tested by Janoshik. Sample RT20 · Batch 2026-06 · Tirzepatide 21.80 mg · Purity 99.721% (HPLC). Analysis date 23 Jun 2026.

Download the Certificate of Analysis (PDF) — verify at janoshik.com/verify with key MP9UX7XUZWKR.